For Immediate Release Contact firstname.lastname@example.org
March 9, 2013
Toshiba’s New Offering Enhances Cardiac Function Assessment
SAN FRANCISCO, March 9, 2013 – For better treatment planning during cardiac resynchronization therapy (CRT), Toshiba America Medical Systems, Inc.’s Activation Imaging is the company’s latest addition to its 3D Wall Motion Tracking software. Activation Imaging is an FDA-cleared, proprietary technology available on the Aplio ArtidaTM cardiovascular ultrasound system.
When the heart is not functioning properly, different segments activate at different moments in time. Activation Imaging, in conjunction with Toshiba’s comprehensive 3D Wall Motion Tracking software, allows clinicians to evaluate dyssynchrony at the onset of the heart’s contraction and to properly identify the left ventricle’s pumping strength and timing for more accurate lead placements in CRT treatment.
“Toshiba continues to pioneer innovative ultrasound technology to improve patient outcomes,” said Tomohiro Hasegawa, director, Ultrasound Business Unit, Toshiba. “Studies show that CRT procedures have a 33 percent failure rate.1 Activation Imaging’s ability to measure dyssynchrony at a more appropriate moment in time, the onset of contraction, will provide greater confidence during CRT planning to improve patient outcomes and lower healthcare costs.”
Toshiba will showcase Activation Imaging at this year’s American College of Cardiology (ACC) annual meeting in San Francisco, March 9 – 11, 2013 (Booth #5733, North Hall).
About Toshiba America Medical Systems, Inc.
With headquarters in Tustin, Calif., Toshiba America Medical Systems (TAMS) markets, sells, distributes and services radiology and cardiovascular systems, including CT, MR, ultrasound, X-ray and cardiovascular equipment, and coordinates clinical diagnostic imaging research for all modalities in the United States. For more information, visit the TAMS website at www.medical.toshiba.com.
About Toshiba Medical Systems Corporation
Toshiba Medical Systems Corporation is a leading worldwide provider of medical diagnostic imaging systems and comprehensive medical solutions, such as CT, X-ray and vascular, ultrasound, nuclear medicine and MRI systems, as well as information systems for medical institutions. Toshiba Medical Systems Corporation has been providing medical products for over 80 years. Toshiba Medical Systems Corporation is a wholly owned subsidiary of Toshiba.
Toshiba is a world-leading diversified manufacturer, solutions provider and marketer of advanced electronic and electrical products and systems. Toshiba Group brings innovation and imagination to a wide range of businesses: digital products, including LCD TVs, notebook PCs, retail solutions and MFPs; electronic devices, including semiconductors, storage products and materials; industrial and social infrastructure systems, including power generation systems, smart community solutions, medical systems and escalators & elevators; and home appliances.
Toshiba was founded in 1875, and today operates a global network of more than 550 consolidated companies, with 202,000 employees worldwide and annual sales surpassing 6.1 trillion yen (US$74 billion). Visit Toshiba’s website at www.toshiba.co.jp/index.htm.
1 Abraham WT, Fisher WG, Smith AL, et al., MIRACLE Study Group. Multicenter InSync Randomized Clinical Evaluation. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002;346: 1845–53.